MYC and cancer: Seven SNPs associated with cancer risk map to the cancer-specific MYC enhancers (Extended Data Fig. 7l), including the COAD risk variant rs6983267 that has been replicated in multiple cohorts46–50, suggesting that these variants exert their effect by impacting MYC expression in transformed cells rather than immune or stromal cells.